Parkinson’s Disease Psychosis Associated Comorbidities, and Mortality in the Medicare Population
Objective: To characterize patients with Parkinson’s disease psychosis (PDP) in the Medicare database, determine comorbidities associated with PDP, and evaluate mortality in PDP compared to…Underserved Patient Access to Movement Disorders Care: Experience from a Tertiary Academic Referral Center
Objective: To explore geographical and clinic-demographical profile of underserved patients in Florida diagnosed with movement disorders. Background: Movement disorders are complex conditions that often require…Inpatient care for Parkinson’s disease in Germany: Analysis of more than one million cases from the years 2010 to 2015
Objective: Analyze the characteristics and dynamics of inpatient care for Parkinson's disease in Germany. Background: Parkinson's disease is the most common neurodegenerative movement disorder with…A 15-year review of a movement disorder database in Singapore
Objective: To establish the prevalence and demographical characteristics of patients seen in a Movement Disorders (MD) Centre. Background: Movement disorders contribute to a significant proportion…Mortality from Parkinson’s disease in China: Findings from a Ten-year follow up study in Shanghai
Objective: To examine the outcome, including overall and cause-specific mortality, of PD patients subsequent to 10 years of surveillance in Shanghai, China. This is an…Anemia in men and increased Parkinson’s disease risk: A population-based cohort study using big data
Objective: To evaluate hemoglobin (Hb) levels changes preceding PD diagnosis and the association with PD risk. Background: Alteration of iron levels in the brain has…Prevelance in the World
Objective: To analyze the static data in the incidence of Parkinson disease in the world. Background: Parkinson’s disease is considered a progressive multisystem disorder involving…Antihypertensive medications have protective associations with PD outcomes in PD-hypertension
Objective: We explored the associations between markers of clinical decline and antihypertensive use in subjects with both Parkinson disease (PD) and hypertension (HTN) Background: Comorbid…Prevalence and characteristics of patients with progressive supranuclear palsy (PSP) in US health insurance claims data
Objective: To estimate the prevalence of PSP in the United States (US) and present a profile of PSP patients. Background: Progressive supranuclear palsy (PSP) is…Prevalence and influence of co-pathologies in patients with autopsy-confirmed Lewy body disorders: A systematic review
Objective: To determine the prevalence of selected co-pathologies in patients with Lewy Body disorders, as well as their influence on disease expression. Background: The presence…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.